Integrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension

被引:0
作者
Jordana B. Cohen
Debbie L. Cohen
机构
[1] Hospital of the University of Pennsylvania,Renal, Electrolyte and Hypertension Division
来源
Current Cardiology Reports | 2016年 / 18卷
关键词
White-coat hypertension; Masked hypertension; Hypertension screening; Ambulatory blood pressure monitoring; Home blood pressure monitoring;
D O I
暂无
中图分类号
学科分类号
摘要
Guidelines for the diagnosis and monitoring of hypertension were historically based on in-office blood pressure measurements. However, the US Preventive Services Task Force recently expanded their recommendations on screening for hypertension to include out-of-office blood pressure measurements to confirm the diagnosis of hypertension. Out-of-office blood pressure monitoring modalities, including ambulatory blood pressure monitoring and home blood pressure monitoring, are important tools in distinguishing between normotension, masked hypertension, white-coat hypertension, and sustained (including uncontrolled or drug-resistant) hypertension. Compared to in-office readings, out-of-office blood pressures are a greater predictor of renal and cardiac morbidity and mortality. There are multiple barriers to the implementation of out-of-office blood pressure monitoring which need to be overcome in order to promote more widespread use of these modalities.
引用
收藏
相关论文
共 212 条
[1]  
Egan BM(2010)US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008 JAMA 303 2043-2050
[2]  
Zhao Y(2012)Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis PLoS Med 9 e1001293-957
[3]  
Axon RN(2013)Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis CMAJ 185 949-2304
[4]  
Lv J(2014)Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels—overview and meta-analyses of randomized trials J Hypertens 32 2296-158
[5]  
Neal B(2003)Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force Am J Prev Med 25 151-U747
[6]  
Ehteshami P(2007)Evidence for the reaffirmation of the U. S. Preventive Services Task Force recommendation on screening for high blood pressure Ann Intern Med 147 787-438
[7]  
Lv J(2013)Are there consequences of labeling patients with prehypertension? An experimental study of effects on blood pressure and quality of life J Psychosom Res 74 433-583
[8]  
Ehteshami P(2010)Effects of labeling patients as prehypertensive J Am Board Fam Med 23 571-177
[9]  
Sarnak MJ(1981)Longterm follow-up of absenteeism among working men following the detection and treatment of their hypertension Clin Invest Med 4 173-204
[10]  
Thomopoulos C(2015)Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 162 192-786